Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia

B-cell chronic lymphocytic leukaemia (CLL) is associated with immunosuppression and patients are at increased clinical risk following SARS-CoV-2 infection. Covid-19 vaccines offer the potential for protection against severe infection but relatively little is known regarding the profile of the antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, H., McIlroy, G., Bruton, R., Ali, M., Stephens, C., Damery, S., Otter, A., McSkeane, T., Rolfe, H., Faustini, S., Wall, N., Hillmen, P., Pratt, G., Paneesha, S., Zuo, J., Richter, A., Moss, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323747/
https://www.ncbi.nlm.nih.gov/pubmed/34330895
http://dx.doi.org/10.1038/s41408-021-00528-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323747/
https://www.ncbi.nlm.nih.gov/pubmed/34330895
http://dx.doi.org/10.1038/s41408-021-00528-x

Ejemplares similares